Leap Therapeutics, Inc.

LPTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$47,249$70,643$20,993$114,916
Short-Term Investments$0$0$22,764$0
Receivables$704$771$1,363$1,189
Inventory$0$0$1,396$0
Other Curr. Assets$86$183$6,699$769
Total Curr. Assets$48,039$71,597$53,215$116,874
Property Plant & Equip (Net)$262$262$371$495
Goodwill$0$0$0$0
Intangibles$0$0$25$0
Long-Term Investments$0$0$150$0
Tax Assets$0$0$0$159
Other NC Assets$823$966$4,330$383
Total NC Assets$1,085$1,228$4,876$1,037
Other Assets$0$0$0$0
Total Assets$49,124$72,825$58,091$117,911
Liabilities
Payables$4,743$6,465$1,541$4,189
Short-Term Debt$266$262$268$432
Tax Payable$531$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,536$5,957$1,309$5,366
Total Curr. Liab.$14,076$12,684$3,118$9,987
LT Debt$0$0$256$37
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$75$0
Total NC Liab.$0$0$331$37
Other Liabilities$0$0$0$0
Cap. Leases$266$262$524$469
Total Liabilities$14,076$12,684$3,449$10,024
Equity
Pref Stock$0$0$0$0
Common Stock$38$26$142$88
Retained Earnings-$467,371-$399,582-$105,932-$263,572
AOCI-$120$106$0-$267
Other Equity$502,501$459,591$160,432$371,638
Total Equity$35,048$60,141$54,642$107,887
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$49,124$72,825$58,091$117,911
Net Debt-$46,983-$70,381-$20,469-$114,447